Volitionrx ltd (VNRX)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Revenues
Service

-

-

16

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalty

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product sales

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalty

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total Revenues

0

-

17

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

-14

14

0

0

0

0

0

0

0

27

11

15

0

0

0

0

Operating Expenses
Professional fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

400

424

447

465

352

236

551

121

119

165

127

311

153

92

64

51

68

67

63

102

21

18

26

Salaries and office administrative fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

857

506

322

376

611

301

339

404

457

41

171

97

179

191

198

144

150

167

204

-

347

161

-

Salaries and office administrative fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

60

Research and development

3,894

2,767

2,642

2,478

2,474

3,059

2,737

2,686

2,423

2,416

2,133

1,807

1,668

2,724

1,968

1,749

1,462

1,671

1,862

1,356

1,210

1,310

1,071

791

870

745

524

640

593

1,068

633

559

511

615

292

415

198

General and administrative

1,703

739

1,354

1,407

1,229

884

1,450

1,643

1,842

1,449

1,555

1,427

1,400

3,619

163

166

228

157

141

122

247

49

129

51

68

191

67

123

51

212

48

149

38

97

54

45

49

Sales and marketing

273

247

195

238

284

310

259

235

364

174

185

207

269

98

88

128

31

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of patents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Total Operating Expenses

5,872

3,754

4,193

4,124

3,988

4,255

4,447

4,565

4,629

4,040

3,875

3,442

3,338

3,483

3,479

2,975

2,492

2,671

2,967

2,017

2,349

1,885

1,778

1,050

1,238

1,695

925

1,047

907

1,477

900

943

817

-

-

640

335

Operating Loss

-5,871

-3,754

-4,176

-4,124

-3,988

-4,255

-4,447

-4,565

-4,629

-4,040

-3,875

-3,442

-3,338

-3,483

-3,479

-2,975

-2,492

-2,671

-2,967

-2,017

-2,349

-1,900

-1,763

-1,050

-1,238

-1,695

-925

-1,047

-907

-1,477

-872

-931

-801

-

-

-

-

Other Income (Expenses)
Grant income

7

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

38

-

-

-

11

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

27

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on derivative remeasurement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

Interest expense

-33

-97

-32

33

-30

-131

-29

26

22

22

17

20

12

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Grants received

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

143

-

-

-

-

-

-

-

-

-

-

-

-

Other expenses

-

-

-

-

-

-

-

-

-22

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Grants received

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

25

-

-

0

146

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Other expenses

-

37

-4

-33

-196

-

-29

-26

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on derivative re-measurement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

339

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain / (loss) on derivative re-measurement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,130

-1,867

1,100

-

-

-

-

-

-

-

-

-

-

-

-

Total Other Expenses

-

-

-

-

-

-

-

-

-

-

-

-

-12

-

0

25

-

-15

0

146

339

958

-4,130

1,867

-956

-

-

-

-

-

-

-

-

-

-

-

-

Derivative expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Total Other Income (Expenses)

12

-

-

-

-215

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Provision for Income Taxes

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

-9

4

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

-

Net Loss

-5,859

-3,557

-4,180

-4,157

-4,203

-4,287

-4,476

-4,592

-4,652

-4,062

-3,892

-3,462

-3,350

-2,984

-3,479

-2,949

-2,492

-2,686

-2,962

-1,870

-2,010

-941

-5,893

816

-2,194

-

-925

-1,047

-

-

-

-

-

-

-

-640

-

Net Loss attributable to Non-Controlling Interest

9

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Loss attributable to VolitionRx Limited Stockholders

-5,849

-

-

-

-4,203

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total Operating Expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

715

-

-

Net Loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-907

-

-872

-931

-801

-

-715

-

-335

Other Comprehensive Income (Loss)
Foreign currency translation adjustments

373

-

-

-

-24

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Comprehensive Loss

-5,485

-

-

-

-4,227

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency translation adjustments

-

-

401

49

-

-

46

132

14

3

-32

61

31

-75

15

-67

18

-18

14

45

-21

-10

-19

-9

-4

-7

-6

-12

1

6

-6

-35

-3

-

-

-

-

Total Other Comprehensive Income/(Loss)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15

-67

18

-18

14

45

-21

-10

-19

-9

-4

-7

-6

-12

1

6

-6

-35

-3

-

-

-

-

Net Comprehensive Loss

-

-

-3,779

-4,107

-

-

-4,430

-4,459

-4,637

-4,059

-3,925

-3,401

-3,319

-3,059

-3,463

-3,016

-2,474

-2,705

-2,948

-1,825

-2,031

-952

-5,913

807

-2,198

-836

-932

-1,060

-906

-1,470

-878

-967

-805

-

-

-

-

Net Loss Per Share - Basic and Diluted attributable to VolitionRx Limited

-0.14

-0.08

-0.10

-0.11

-0.12

-0.11

-0.14

-0.15

-0.17

-0.15

-0.15

-0.13

-0.13

-0.11

-0.15

-0.13

-0.13

-0.16

-0.16

-0.10

-0.12

-

-

-

-0.18

-

-

-

-0.09

-0.16

-0.09

-0.10

-0.09

-0.12

-0.12

-0.13

-0.08

Weighted Average Shares Outstanding
Basic and Diluted

41,197

41,752

39,880

38,876

36,212

35,437

32,826

30,027

27,265

26,533

26,512

26,383

26,128

25,969

23,524

23,412

19,289

18,477

18,042

17,945

16,461

-

-

-

12,246

-

-

-

-

-

-

-

-

-

-

-

-

Net Loss per Share - Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.44

0.06

-

-

-0.08

-0.10

-

-

-

-

-

-

-

-

-

Net Loss per Share - Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.44

0.06

-

-

-

-0.10

-

-

-

-

-

-

-

-

-

Weighted Average Shares Outstanding - Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,524

13,388

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted Average Shares Outstanding - Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,524

13,887

-

-

-

10,642

-

-

-

-

-

-

-

-

-

Weighted Average Shares Outstanding - Basic and Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,086

10,642

-

-

-

-

-

-

-

-

-

Weighted Average Shares Outstanding - Basic and Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,210

-

9,697

9,031

8,645

8,286

5,898

4,742

4,146